Analysis of Clinical Characteristics of Breast Cancer Patients With the Japanese Founder Mutation BRCA1 L63X

Oncotarget - United States
doi 10.18632/oncotarget.26852
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Founder BRCA1/2 Mutations Among Male Patients With Breast Cancer in Israel

American Journal of Human Genetics
Genetics
1999English

BRCA1 (185delAG) Mutation Among Egyptian Breast Cancer Female Patients

Journal of High Institute of Public Health
2008English

BRCA1 Novel Mutation V1736D and in Silico Analysis of SNP Q356R in Sudanese Patients With Breast Cancer

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

BRCA1 Novel Mutation V1736D and in Silico Analysis of SNP Q356R in Sudanese Patients With Breast Cancer

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Performance of BRCA1/ 2 Mutation Prediction Models in Male Breast Cancer Patients

Clinical Genetics
Genetics
2017English

High Prevalence of a BRCA1 Gene Founder Mutation, 5083del19, in Unselected Breast–ovarian Cancer Patients From Southern Italy: Genotype–phenotype Correlations

Breast Cancer Research
Cancer ResearchOncology
2005English

Prevalence of the BRCA1 Founder Mutation C.5266dupin Brazilian Individuals At-Risk for the Hereditary Breast and Ovarian Cancer Syndrome

Hereditary Cancer in Clinical Practice
OncologyGenetics
2011English

Erratum: Corrigendum: BRCA1 Genomic Deletions Are Major Founder Mutations in Dutch Breast Cancer Patients

Nature Genetics
Genetics
1997English

What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?

Archives of Breast Cancer
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy